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Abstract
Background While Western literature has mostly
reported the incidence of deep vein thrombosis (DVT) and
pulmonary embolism (PE) after TKA with chemoprophy-
laxis, the Asian literature still has mostly reported the
incidence without chemoprophylaxis. This may reflect a
low incidence of DVT and PE in Asian patients, although
some recent studies suggest the incidence after TKA in
Asian patients is increasing. Moreover, it is unclear
whether the incidence of DVT and PE after TKA is simi-
larly low among different Asian countries.
Questions/purposes We therefore determined the overall
incidence of symptomatic PE and DVT without chemo-
prophylaxis after TKA in the Asian population, determined
whether the incidence had a tendency to increase over time
in Asia, and compared the incidence of symptomatic PE
and DVT among Asian countries through a meta-analysis.
Methods We searched the PubMed, Embase, Cochrane
Library, Web of Science, and Google Scholar websites for
prospective studies published between 1996 and 2011.
A total of 1947 patients from 18 studies were reviewed for
meta-analysis.
Results The incidence of symptomatic PE was 0.01%. The
incidences of overall DVT, proximal DVT, and symptomatic
DVT were 40.4%, 5.8% and 1.9%, respectively. We found
no difference in incidence of symptomatic PE among Asian
countries and no trends in changes of the incidence over time.
Conclusions The incidence of symptomatic PE and DVT
after TKA without prophylaxis is low in Asian countries
and has not changed over time, despite Westernizing life-
styles and an aging populace. Further investigation with
large randomized studies is necessary to confirm our
findings and identify risk factors predisposing to DVT.
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Introduction
Deep vein thrombosis (DVT) after TKA is a common and
relatively benign treatable condition, while pulmonary
embolism (PE) is frequently life-threatening and sometimes
fatal. The literature suggests a substantial variation exists in
the rates of DVT and PE in different countries after TKA
[23]. Several recent Asian reports [13, 24, 30, 34] suggest
an incidence of PE of 0% to 1.3% and an incidence of DVT
of 26.6% to 60.8% after TKA without chemoprophylaxis. A
number of studies [7, 8, 12, 15, 18, 24, 26, 27, 29] show the
incidence of DVT and PE is relatively lower in Asian
countries than in Western countries. However, several
recent studies [5, 13, 42] suggest the incidence after TKA in
Asian patients is comparable to that in Western populations.
One meta-analysis focusing on the rate of DVT and PE after
major hip and knee surgery from Asia [23] reported lower
rates of proximal DVT (8.7% after TKA and 9.6% after hip
surgery) in Asian countries than in Western countries
([ 20% after major hip surgery) [12, 16]. Furthermore, the
authors questioned the true advantage of routine chemo-
prophylaxis in the Asian population since they found no
reported deaths due to PE regardless of a possible trend of
increasing incidence of proximal DVT. That study, how-
ever, included not only hip and knee arthroplasties but also
hip fracture surgery. Moreover, it was unclear whether the
incidence of PE and DVT without chemoprophylaxis after
TKA is similarly low among different Asian countries.
We therefore determined (1) the overall incidence of
symptomatic PE and DVT after TKA without chemopro-
phylaxis in Asian populations, (2) whether the rates of
symptomatic PE and proximal DVT have increased over
time in Asian patients, and (3) the differences in the
incidence of symptomatic PE and DVT among different
Asian countries through a meta-analysis.
Search Strategy and Criteria
We performed a systematic review and meta-analysis
under the Meta-analysis of Observational Studies in Epi-
demiology guidelines [38] and the Cochrane Reviewers’
Handbook [17]. We systematically searched the PubMed,
Embase, Cochrane Library, Web of Science, and Google
Scholar websites for publications published between Jan-
uary 1996 and December 2011. The database search was
performed using the terms shown in Appendix 1. We
applied the search to English language titles and abstracts.
The reference lists of identified studies and key review
articles were also searched. Using this search strategy, we
identified 5432 articles (Fig. 1).
Of these, we included only randomized clinical trials
and prospective cohort studies reporting the incidence of
DVT and PE after TKA in the Asian population. DVT had
to be confirmed by venography, ultrasonography, or CT
venography (Table 1). Imaging studies for DVT had to be
the routine practice after TKA. For symptomatic PE,
clinical symptoms had to be determined by perfusion or
ventilation scintigraphy, pulmonary angiography, or spiral
CT. Studies were excluded if patients received anticoagu-
lants prophylaxis or mechanical prophylaxis (eg, foot
pumps, intermittent pneumatic compression devices, etc)
during or after surgery. Three authors (HSK, HJL, SSS)
independently screened the 5432 titles and abstracts and
reviewed the published articles to assess suitability for
inclusion. Disagreements were resolved by consensus.
Fig. 1 A flowchart shows the selection
process of studies.
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After removing nonscientific or basic research articles not
related to the topic, we identified 246 studies. There were
154 studies after removing duplicates. Forty of 154 studies
satisfied the inclusion criteria. Two of us (WSL, SSS) then
reviewed the full text of 40 articles. We excluded 22 arti-
cles based on overlapping cohorts, review article,
inadequate data, mechanical prophylaxis, and inadequate
imaging studies (Fig. 1). These 22 exclusions left 18
studies (three randomized controlled trials and 15 pro-
spective observation studies) involving 1947 patients [2–5,
10, 13, 14, 21, 24, 28, 29, 32, 35, 39–42, 45]. Of the 18
studies, six were conducted in Taiwan [3, 39–42, 45], three
in Korea [2, 24, 28], two in Japan [13, 14], two in Thailand
[5, 35], two in Singapore [4, 32], and one each in Hong
Kong [29], Malaysia [10], and India [21] (Table 1). Two
authors (WSL, KIK) assessed study quality using the
Newcastle-Ottawa Scale [43], which evaluates studies on
selection, comparability, and outcome in cohort studies.
Inconsistencies were resolved by consensus between the
two authors. No difference in quality was observed
between the studies.
For data extraction, we used the following information
from each study: midyear of surgery, number of patients,
patient characteristics, country, imaging methods for DVT
and PE, and thromboembolic events (Table 1). To assess
DVT and PE events, we recorded cases of overall DVT,
proximal DVT, distal DVT, symptomatic DVT, symp-
tomatic PE, fatal PE, and death after surgery. Overall DVT
was defined as DVT confirmed by routine radiographic
studies regardless of DVT symptoms. Proximal DVT was
defined when thrombosis developed in the popliteal vein
and above. If thrombi were detected in both proximal and
distal veins, DVTs were classified as proximal DVT. Two
reviewers (WSL, KIK) extracted all data independently,
according to the selection criteria. Inconsistencies in the
extracted data were settled by consensus.
To identify the incidences of overall DVT, proximal
DVT, distal DVT, symptomatic DVT, and symptomatic PE,
we pooled DVT and PE events among the studies using
random-effects or fixed-effects models, depending on the
heterogeneity of the included studies. The random-effects
model was utilized by applying the method of DerSimonian
and Laird [9], and the fixed-effects model was utilized by
applying the method of Mantel and Haenszel [31]. We
tested for heterogeneity by calculating the I2 tests and
interpreting I2 values of greater than 50% as indicating
heterogeneity [17]. We found heterogeneity among the
studies for overall DVT (I2 = 98.9%), proximal DVT



















Dhillon et al. [10] 1993 Malaysia PC Venography 34 26 NA NA 1
Fujita et al. [14] 1995 Japan PC Venography 138 67 20 NA 2
Nathan et al. [32] 1997 Singapore PC Ultrasonography 137 6 6 NA 0
Wang et al. [40] 1998 Taiwan PC Venography 105 66 3 46 0
Ko et al. [29] 2000 Hong
Kong
PC Ultrasonography 58 18 9 NA 1
Wang et al. [42] 2000 Taiwan RCT Venography 239 122 12 NA 0
Fuji et al. [13] 2001 Japan RCT Venography 79 48 6 NA 1
Wang et al. [39] 2001 Taiwan PC Venography 55 32 4 20 0
Wang et al. [41] 2001 Taiwan RCT Venography 51 36 3 15 0
Pookarnjanamorakot
et al. [35]
2001 Thailand PC Venography 67 16 10 0 0
Kim et al. [28] 2002 Korea PC Venography 264 58 13 2 0
Chen et al. [3] 2002 Taiwan PC Venography 78 31 1 9 0
Jain et al. [21] 2002 India PC Ultrasonography 26 0 0 NA 0
Chin et al. [4] 2003 Singapore PC Ultrasonography 110 24 3 NA 1
Chotanaphuti et al.
[5]
2003 Thailand PC Venography 100 61 12 NA 1
Cha et al. [2] 2007 Korea PC CT venography 57 22 7 NA NA
Kim et al. [24] 2008 Korea PC Ultrasonography 297 79 9 0 0
Yang et al. [45] NA Taiwan PC Venography 52 19 NA NA NA
DVT = deep vein thrombosis; PE = pulmonary embolism; PC = prospective cohort; RCT = randomized controlled trial; NA = not available.
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(I2 = 87.2%), distal DVT (I2 = 98.6%), and symptomatic
DVT (I2 = 95.9%). Therefore, we used the random-effects
model to pool the DVT events. There was no heterogeneity
among the studies for symptomatic PE (I2 = 0.0%). We
used the fixed-effects model to pool the symptomatic PE
events. Subgroup analyses were conducted based on mid-
year of research and country in each study. To determine
whether the incidences of symptomatic PE and proximal
DVT in Asian populations changed over time, we used the
year of surgery or research rather than the year of publi-
cation in each study. Because publishing a paper takes a
long time, sometimes many years, time periods during
which surgeries were performed were believed to be a more
valid surrogate for time. Therefore, to assess temporal
trends in the incidence of symptomatic PE and proximal
DVT, we enrolled 17 studies and stratified the midyear of
surgery of each study (range, 1993–2008) into three time
periods: 1993 to 1998 (414 patients) [10, 14, 32, 40], 1999
to 2002 (917 patients) [3, 13, 21, 28, 29, 35, 39, 41, 42], and
2003 to 2008 (564 patients) [2, 4, 5, 24]. The incidence
ratios (IRs) of proximal DVT and symptomatic PE at the
last two time periods were compared with the first time
period as a reference. For the analysis by country, there had
to be at least two studies from a country and the pooled
number of patients had to be more than 100. The incidences
of overall DVT, proximal DVT, and symptomatic PE in
other Asian countries with available data were compared
with those of Taiwan, from which the greatest number of
studies were reported.
To assess the publication bias, we conducted funnel
plots and visually evaluated their symmetry. Rates of
overall DVT were broadly symmetrical and rates of PE
were narrowly symmetrical. Statistical analyses were
conducted using Stata1 10 software (StataCorp LP, Col-
lege Station, TX, USA).
Results
Symptomatic PE was rare and the incidence for proximal
DVT was low. The incidence of symptomatic PE was
0.01% (95% CI, 0.00–0.07) in 16 studies [3–5, 10, 13, 14,
21, 24, 28, 29, 32, 35, 39–42], which included 1838 patients
(Fig. 2). No fatal PE was reported in any of these studies.
The incidence of overall DVT (asymptomatic and symp-
tomatic) after TKA was 40.4% (95% CI, 28.5–52.3). The
incidences varied from 0% to 76% depending on the study
(Fig. 3). Sixteen studies [2–5, 13, 14, 21, 24, 28, 29, 32, 35,
Fig. 2 The forest plot shows rates of symptomatic PE with a table of summarized data in Asian countries. The incidence of symptomatic PE was
extremely low (0.01%; 95% CI, 0.00–0.07).
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39–42], which included 1861 patients, reported incidences
of proximal DVT and distal DVT, which were 5.8% (95%
CI, 3.7–7.9) (Fig. 4) and 26.6% (95% CI, 23.6–29.6)
(Fig. 5), respectively. Seven studies [3, 24, 28, 35, 39–41],
which included 917 patients, provided data on incidence of
symptomatic DVT: 1.9% (95% CI, 0.6–3.1) (Fig. 6).
The incidences of symptomatic PE and proximal DVT
in more recent two time periods were similar to those of the
first time period, and no increasing temporal patterns were
observed between the earlier and more recent time periods.
The incidence of symptomatic PE was 0.017% from period
2003 to 2008 [4, 5, 24], 0.012% in 1999 to 2002 [3, 13, 21,
28, 29, 35, 39, 41, 42], and 0.017% in 1993 to 1998 [10, 14,
32, 40] (Fig. 7). With the period 1993 to 1998 as a refer-
ence, we identified similar incidences of symptomatic PE
between the periods 2003 to 2008 (IR = 1.00; 95% CI,
0–?) and 1999 to 2002 (IR = 0.71; 95% CI, 0–?). The
incidences of proximal DVT were 5.92% from 2003 to
2008 [2, 4, 5, 24], 5.47% from 1999 to 2002 [3, 13, 21,
28, 29, 35, 39, 41, 42], and 6.69% from 1993 to 1998
[14, 32, 40] (Fig. 7). With the period 1993 to 1998 as a
reference, there were no differences in incidences of
proximal DVT between patients observed from 1999 to
2002 (IR = 0.82; 95% CI, 0.52–1.28) and 2003 to 2008
(IR = 0.89; 95% CI, 0.55–1.43).
Among the different Asian countries, the incidences of
symptomatic PE were similar, but the incidences of overall
and proximal DVT were dissimilar. Compared with Tai-
wan as a reference, there was no difference in incidences of
overall DVT in Japan (IR = 1.02; 95% CI, 0.88–1.18), but
there were lower incidences of overall DVT in Thailand
(IR = 0.78; 95% CI, 0.66–0.97), Korea (IR = 0.51;
95% CI, 0.44–0.59), and Singapore (IR = 0.24; 95% CI,
0.17–0.34) (Fig. 8). We identified higher incidences of
proximal DVT in Japan (11.04%) (IR = 3.11; 95% CI,
1.73–5.57) and Thailand (13.05%) (IR = 3.67; 95% CI,
2.03–6.64) but similar incidences in Korea (4.76%)
(IR = 1.34; 95% CI, 0.76–2.36) and Singapore (3.46%)
(IR = 0.97; 95% CI, 0.44–2.15), compared with Taiwan
(3.55%) (Fig. 8).
Fig. 3 The forest plot shows rates of overall DVT with a table of summarized data in Asian countries. The incidence of overall DVT after TKA
was 40.4% (95% CI, 28.5–52.3).
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Discussion
In contrast to the Western literature, which has typically
reported the incidence of PE and DVT after TKA with che-
moprophylaxis, most Asian literature has reported the
incidence without chemoprophylaxis [7, 8, 12, 18, 24, 26, 27,
29]. This may reflect a low incidence of DVT and PE after
TKA in Asian populations even without chemoprophylaxis.
Only one meta-analysis study of the incidence of PE and
DVT after major orthopaedic surgery has been reported from
Asia so far and it suggested rates of proximal DVT and
symptomatic PE lower than those in Western reports [23].
However, that study included not only TKAs but also THAs
and hip fractures. Since the incidence and pattern of PE and
DVT after TKA, THA, and hip fracture are not same [11, 12,
16, 44], that study could not give a clear indication of the
incidence of PE and DVT after TKA. It has been also unclear
whether the incidence of PE and DVT after TKA is similarly
low among Asian countries. Furthermore, several recent
studies have reported the incidence after TKA in Asian
patients is increasing [5, 13, 42]. We therefore determined
(1) the overall incidence of symptomatic PE and DVT after
TKA without chemoprophylaxis in the Asian population,
(2) whether the rates of symptomatic PE and proximal DVT
have increased over time in Asian patients, and (3) the
incidences of symptomatic PE and DVT among Asian
countries through a meta-analysis.
In our systematic survey, we identified a number of lim-
itations in the literature, and our survey methods were also
associated with some limitations. First, methods for detect-
ing DVT were not the same in the 18 studies enrolled.
Venography was used in 12 studies, ultrasonography in five
studies, and CT venography in one study (Table 1).
Although invasive venography was considered the classical
standard in the diagnosis of DVT, the noninvasive ultraso-
nography now is widely used and has been proven to have
almost equal sensitivity and specificity [1, 46]. Furthermore,
the American College of Radiology Appropriateness Crite-
ria1 recently recommended the use of ultrasonography for
initial evaluation of DVT rather than venography [19].
Second, a limited number of studies have been published in
each country. Although we did our best to find more publi-
cations from more countries, we used only eight countries
with 18 articles to assess the differences in incidences among
the countries. We found no additional literature satisfying
our inclusion criteria, such as no prophylaxis and routine
Fig. 4 The forest plot shows rates of proximal DVT with a table of summarized data in Asian countries. The incidence of proximal DVT after
TKA was 5.8% (95% CI, 3.7–7.9).
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radiographic evaluation for DVT regardless of any symp-
toms. Third, our study does not convey information on the
effects of potential risk factors for DVT or PE, such as age,
sex, obesity, types of anesthesia, or operation time, because
relevant data were not available in most included studies.
Therefore, we cannot suggest risk factors for DVT or PE.
Finally, we lacked control data from Western countries to
compare differences in the incidence of PE and DVT
between Asian and Western populations. Although we
considered inclusion of control groups in Western patients,
Fig. 5 The forest plot shows rates of distal DVT with a table of summarized data in Asian countries. The incidence of distal DVT after TKA was
26.6% (95% CI, 23.9–29.6).
Fig. 6 The forest plot shows rates of symptomatic DVT with a table of summarized data in Asian countries. The incidence of symptomatic DVT
after TKA was 1.9% (95% CI, 0.6–3.1).
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we found no comparable study without prophylaxis after
TKA in Western patients. Hence, we only briefly mentioned
the difference compared with the usual Western literature for
the reference.
Our meta-analysis showed the incidence of overall DVT
was 40.4%, but the incidences of proximal and symptom-
atic DVT were 5.8% and 1.9%, respectively. Since distal
DVT is typically stable and usually does not progress to PE
[22, 27, 33, 36], most surgeons focus on proximal DVT.
Moreover, the incidence of symptomatic PE was 0.01%
and there were no deaths related to DVT or PE. Our
findings were similar to those reported in one meta-analysis
from Asia [23], although that study included not only
TKAs but also THAs and hip fracture surgeries. While we
found no control (without chemoprophylaxis) studies of
Western patients, our findings showed incidences of
symptomatic PE and proximal DVT after TKA that seem
low compared to those in Western studies [15] reporting an
incidence of DVT of 41% to 85% without prophylaxis and
an incidence of proximal DVT of 5% to 22%. Furthermore,
we found no death related to PE and DVT in the Asian
literature. The lower incidence of PE and DVT has been
attributed to the low prevalence of obesity, the low fre-
quency of hyperlipidemia, and the absence of some genetic
factors in the Asian population [25, 26, 28]. Differences in
the dietary patterns (vegetarian versus nonvegetarian diets)
have also been suggested as one of the causes of the low
risk of DVT [30]. Kim and Kim [25] suggested the absence
of thrombophilic polymorphisms with low clinical pro-
thrombotic risk factors make the occurrence of PE after
THA rare in the Asian population. Similar low rates are
seen in Asians living in the West [37]. However, the rea-
sons why the incidence of symptomatic DVT or PE is low
in Asian patients after TKA even without chemoprophy-
laxis are still not clear.
Recent epidemiologic studies [6, 30, 34] have reported
relatively high incidences of DVT and PE in the Asian
population after TKA. Moreover, a previous meta-analysis
from Asia [23] suggested a possible trend toward increas-
ing incidence of proximal DVT. The Scottish Arthroplasty
Project showed PE and DVT rates that have remained
unchanged between 1992 and 2001 despite improved pro-
phylaxis usage during this period [20]. In contrast, one
Western systematic review article [44] reported a
decreasing trend of development of proximal DVT after
TKA with time. Finally, we found no evidence of a recent
increasing tendency of PE and DVT in Asia, which differed
from the results of the previously mentioned Asian meta-
analysis [23]. That study enrolled 14 studies, with midyear
of patient recruitment ranging from 1979 to 2003 for
assessment; among these 14 studies, only seven studies
related to TKA, with midyear ranging from 1993 to 2003.
Moreover, that study enrolled not only TKAs but also
THAs and hip fractures for assessing the temporal trend.
We performed our assessment by focusing purely on TKAs
with longer observation periods and collected from the
most recent literature. These might be reasons why the
trend of incidence of PE and DVT over time was different
between these two meta-analyses from Asia.
The comparisons among Asian countries suggest,
despite the overall low incidence of symptomatic DVT or
PE in the region, considerable variances may exist among
Asian countries. Although Malaysia had the highest inci-
dence of DVT and India had the lowest incidence
(Table 1), we identified only one study in each country that
matched our criteria, and each sample was small (\ 100
patients). Excluding these countries plus Hong Kong with a
small sample size as well, there was a difference in the
incidence of DVT among countries, such as Singapore
(12.7%), Korea (26.9%), Thailand (42.5%), and Japan
(54.2%), compared to Taiwan (53.2%). We identified no
clear reason why the various countries had different
reported incidences. Two studies [2, 35] had a much higher
Fig. 7 A graph shows the incidences of symptomatic PE and
proximal DVT stratified by midyear of study. The incidences of
symptomatic PE and proximal DVT did not increase over time in
Asian patients.
Fig. 8 A graph shows the reported incidences of symptomatic PE,
proximal DVT, and overall DVT per country. The incidences of
overall and proximal DVT were different among Asian countries, but
the incidences of symptomatic PE were similarly low.
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incidence of PE than any other Asian countries because the
studies reported the incidence of PE with asymptomatic PE
included while other studies [3–5, 10, 13, 14, 21, 24, 28,
29, 32, 39–42] reported only the incidence of symptomatic
PE. Therefore, if we exclude asymptomatic PE in the
previously mentioned studies [2, 35], the incidence of
symptomatic PE might be similar in each country; specif-
ically, it was extremely low. Considering the differences
among Asian countries, data acquired from each country
might be considered in developing optimal DVT preven-
tion guidelines for a country.
In conclusion, our study demonstrates the reported
incidences of symptomatic PE and proximal DVT after
TKA were low even without chemoprophylaxis in Asian
patients. No increasing temporal patterns were identified
for the incidence of symptomatic PE or proximal DVT,
regardless of the Westernizing lifestyles and an increas-
ingly aging populace. Hence, routine chemoprophylaxis
following Western protocols after TKA is still debatable in
Asian populations. Further investigation with large ran-
domized studies is needed to confirm our results and
identify the risk factors that can lead to PE and DVT.
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Appendix 1
Search Strategy Applied to Titles and Abstracts
‘‘venous thromboembolism’’ OR ‘‘deep vein thrombosis’’
OR ‘‘pulmonary embolism’’
AND
‘‘total knee arthroplasty’’ OR ‘‘total knee replacement’’
OR ‘‘total knee replacement arthroplasty’’
AND
‘‘Asia’’ OR ‘‘Asian’’ OR ‘‘Asian country’’ OR ‘‘Korea’’
OR ‘‘China’’ OR ‘‘Hong Kong’’ OR ‘‘Taiwan’’ OR
‘‘Japan’’ OR ‘‘Mongolia’’ OR ‘‘Bangladesh’’ OR ‘‘Cam-
bodia’’ OR ‘‘India’’ OR ‘‘Indonesia’’ OR ‘‘Laos’’ OR
‘‘Malaysia’’ OR ‘‘Myanmar’’ OR ‘‘Nepal’’ OR ‘‘Pakistan’’
OR ‘‘Philippines’’ OR ‘‘Singapore’’ OR ‘‘Sri Lanka’’ OR
‘‘Thailand’’ OR ‘‘Vietnam’’ OR ‘‘Kazakhstan’’ OR
‘‘Kyrgyzstan’’ OR ‘‘Tajikistan’’ OR ‘‘Turkmenistan’’
OR ‘‘Uzbekistan’’ OR ‘‘Afghanistan’’ OR ‘‘Bahrain’’ OR
‘‘Iran’’ OR ‘‘Iraq’’ OR ‘‘Israel’’ OR ‘‘Jordan’’ OR
‘‘Kuwait’’ OR ‘‘Lebanon’’ OR ‘‘Oman’’ OR ‘‘Qatar’’
OR ‘‘Saudi Arabia’’ OR ‘‘Syria’’ OR ‘‘UAE’’ OR ‘‘Yemen’’
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